These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38282935)

  • 21. Impact of Pregnancy on Hidradenitis Suppurativa Disease Course: A Systematic Review and Meta-Analysis.
    Seivright JR; Villa NM; Grogan T; Parvataneni RK; Thompson AM; Shi VY; Hsiao JL
    Dermatology; 2022; 238(2):260-266. PubMed ID: 34515085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment strategies for hidradenitis suppurativa: real-life data from a tertiary Greek hospital.
    Tsentemeidou A; Sotiriou E; Vakirlis E; Sideris N; Lallas A; Ioannides D
    Arch Dermatol Res; 2022 Apr; 314(3):301-305. PubMed ID: 33094412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa.
    Alavi A; Farzanfar D; Lee RK; Almutairi D
    J Cutan Med Surg; 2018; 22(2):166-174. PubMed ID: 29231053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menses, pregnancy, delivery, and menopause in hidradenitis suppurativa: A patient survey.
    Fernandez JM; Hendricks AJ; Thompson AM; Mata EM; Collier EK; Grogan TR; Shi VY; Hsiao JL
    Int J Womens Dermatol; 2020 Dec; 6(5):368-371. PubMed ID: 33898700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors of Sexual Dysfunction in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study.
    Cuenca-Barrales C; Molina-Leyva A
    Dermatology; 2020; 236(1):37-45. PubMed ID: 31434072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
    Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing perimenstrual flares of hidradenitis suppurativa.
    Collier EK; Price KN; Grogan TR; Naik HB; Shi VY; Hsiao JL
    Int J Womens Dermatol; 2020 Dec; 6(5):372-376. PubMed ID: 33898701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Use of HSQoL-24 in an Assessment of Quality-of-Life Impairment among Hidradenitis Suppurativa Patients: First Look at Real-Life Data.
    Krajewski PK; Marrón SE; Gomez-Barrera M; Tomas-Aragones L; Gilaberte-Calzada Y; Szepietowski JC
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Psoriasis and Hidradenitis Suppurativa in Pregnancy, a Systematic Review.
    Ferrer-Alcala MA; Sánchez-Díaz M; Arias-Santiago S; Molina-Leyva A
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hidradenitis Suppurativa Quality of Life 24 (HSQoL-24) now available for Polish patients: creation and validation of the Polish language version.
    Krajewski PK; Bardowska K; Matusiak Ł; Szepietowska M; Tyczyńska K; Marron SE; Tomas Aragones L; Szepietowski JC
    Postepy Dermatol Alergol; 2022 Dec; 39(6):1053-1058. PubMed ID: 36686006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
    Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sexual impairment in patients with hidradenitis suppurativa: a systematic review.
    Cuenca-Barrales C; Montero-Vílchez T; Szepietowski JC; Matusiak L; Molina-Leyva A
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):345-352. PubMed ID: 32531099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
    Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
    Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
    Fabbrocini G; Ruina G; Giovanardi G; Dini V; Raone B; Venturini M; Caposiena Caro RD; Veraldi S; Cannavò SP; Merlo G; Bertoldi AM; Fiorentini F; Molinelli E; Atzori L; Bongiorno MR; Lo Re M; Skroza N; Lasagni C; Franchi C; Ardigò M; Di Costanzo L; Stingeni L; Amerio P; Sanna F; Pescitelli L; Broganelli P; De Cupis C; Gualberti G; Saragaglia V; Argenziano G
    Dermatology; 2022; 238(3):487-497. PubMed ID: 34474409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of HiSQOL: A Hidradenitis Suppurativa-Specific Quality of Life Instrument.
    Thorlacius L; Esmann S; Miller I; Vinding G; Jemec GBE
    Skin Appendage Disord; 2019 Jun; 5(4):221-229. PubMed ID: 31367600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perception and Knowledge of Hidradenitis Suppurativa in Greece: A Cross-Sectional Study of 1301 Individuals.
    Liakou AI; Papadakis M; Tsantes AG; Tsante KA; Kontochristopoulos G; Marnelakis I; Katoulis A; Grigoriou S; Rigopoulos D
    Indian J Dermatol; 2022; 67(6):835. PubMed ID: 36998814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse pregnancy and maternal outcomes in women with hidradenitis suppurativa.
    Fitzpatrick L; Hsiao J; Tannenbaum R; Strunk A; Garg A
    J Am Acad Dermatol; 2022 Jan; 86(1):46-54. PubMed ID: 34126093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hidradenitis Suppurativa Quality of Life (HiSQOL): creation and validation of the Polish language version.
    Krajewski PK; Matusiak Ł; Szepietowska M; Rymaszewska JE; Jemec GBE; Kirby JS; Szepietowski JC
    Postepy Dermatol Alergol; 2021 Dec; 38(6):967-972. PubMed ID: 35126002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gynecological aspects of hidradenitis suppurativa].
    Kiss N; Plázár D; Lőrincz K; Bánvölgyi A; Valent S; Wikonkál N
    Orv Hetil; 2019 Feb; 160(8):291-299. PubMed ID: 30773037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
    Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
    Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.